M202 Dr. Dienstag (VO to OC): In clinical trials patients with this type of chronic hepatitis B monitored for a year had a progression of fibrosis somewhere in the vicinity of 20 to 30 percent of cases. And we thought that he should be treated with antiviral therapy.